Wu Jie
InvestorHead of APAC at MPM BioImpact
About
Head of APAC region focusing exclusively on early-stage investment and company creation opportunities. Previously spent 16 years at Temasek, most recently as Director of Life Sciences Investment, investing in healthcare companies including Juno Therapeutics and Guardant Health.
Colleagues at MPM BioImpact
Andrew Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Brian Shuster
Entrepreneur Partner at MPM BioImpact
Frequently asked questions
- Who is Wu Jie?
- Head of APAC region focusing exclusively on early-stage investment and company creation opportunities. Previously spent 16 years at Temasek, most recently as Director of Life Sciences Investment, investing in healthcare companies including Juno Therapeutics and Guardant Health.
- Where does Wu Jie work?
- Wu Jie is Head of APAC at MPM BioImpact.